Mark Andrew Kleman

Mark Kleman practices at UNC Hospitals in Chapel Hill, North Carolina, part of University of North Carolina Health Care System.

Mark Kleman's NPI, 1851698237, was assigned on February 21, 2011. Mark Kleman holds North Carolina license 2017-00852.

Mark Kleman's primary practice is UNC Hospitals, at 101 Manning Drive, Chapel Hill, NC 27514 in Orange County. The practice phone is (919) 966-4141.

Mark Kleman's primary practice is UNC Hospitals in Chapel Hill, North Carolina, part of University of North Carolina Health Care System. Mark Kleman is also affiliated with UNC Health Rex. The medical group on file is UNC Faculty Physicians. Dmand AI also links Mark Kleman to 3 more hospitals, 1 therapy and rehab clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Mark Kleman practices, 6 sites in all. Vendor and product names are available with a free account.

Nephrology is Mark Kleman's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Mark Kleman is licensed in North Carolina.

CMS data shows 457 Medicare services from Mark Kleman across 5 procedure codes in 2024, for 155 Medicare patients. Medicare paid $27,752 for them.

CMS counts 155 Medicare patients who saw Mark Kleman in 2024. The largest group is under 65, with 74 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 32% are also on Medicaid. Their average risk score is 4.81, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Mark Kleman's median patient age at 63, with 44% women.

In 2024, Mark Kleman wrote 2,875 Medicare Part D claims for 195 patients. 86% of them were for generic drugs. CMS names the drug for 2,461 of them, across 52 drugs with 11 or more claims each, at $550,920 in total drug cost. In 2023, CMS named 2,025 claims across 49 drugs.

Mark Kleman accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Mark Kleman as offering telehealth.

CMS Open Payments shows 4 general payments to Mark Kleman from 4 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. OPKO Pharmaceuticals, LLC paid the most, $63.